2K1K

NMR structures of dimeric transmembrane domain of the receptor tyrosine kinase EphA1 in lipid bicelles at pH 4.3

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 95% H2O/5% D2O	95% H2O/5% D2O		4.3		313
2	2D 1H-13C HSQC	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 100% D2O	100% D2O		4.3		313
3	3D HNCO	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 100% D2O	100% D2O		4.3		313
4	3D HNCA	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 100% D2O	100% D2O		4.3		313
5	3D HN(CO)CA	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 100% D2O	100% D2O		4.3		313
6	3D HCCH-TOCSY	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 100% D2O	100% D2O		4.3		313
7	3D HNHA	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 95% H2O/5% D2O	95% H2O/5% D2O		4.3		313
8	3D HNHB	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 95% H2O/5% D2O	95% H2O/5% D2O		4.3		313
9	3D 1H-15N NOESY	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 95% H2O/5% D2O	95% H2O/5% D2O		4.3		313
10	3D 1H-15N TOCSY	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 95% H2O/5% D2O	95% H2O/5% D2O		4.3		313
11	3D 1H-13C NOESY	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 100% D2O	100% D2O		4.3		313
12	13C F1-filtered/F3-edited-NOESY	1.5mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 1.5mM EphA1_TM; 100% D2O	100% D2O		4.3		313
13	15N-T1	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 95% H2O/5% D2O	95% H2O/5% D2O		4.3		313
14	15N-T2	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 95% H2O/5% D2O	95% H2O/5% D2O		4.3		313
15	15N-NOE	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 95% H2O/5% D2O	95% H2O/5% D2O		4.3		313
16	2D 1H-15N HSQC	3mM 15N,13C EphA1_TM; 96mM 2H DHPC; 24mM 2H DMPC; 1.5mM NaN3; 1mM EDTA; 10mM phosphate buffer; 95% H2O/5% D2O	95% H2O/5% D2O		6.3		313

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	UNITY	600

NMR Refinement
Method	Details	Software
simulated annealing		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	12
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	chemical shift assignment	CARA	1.5.5, 1.8	Keller and Wuthrich
3	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
4	refinement	CYANA	2.1	Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.